PHIO PHARMACEUTICALS CORP - COM NEW (PHIO)

CUSIP: 71880W303

Q2 2022 13F Holders as of 30 Jun 2022

Share change
+71,908
SEC-reported price per share
$0.71
Number of holders
10
Value change
+$33,902
Number of buys
3
Number of sells
10

Security key

71880W303

Report period

Q2 2022

Institutions

10

Top holders

10

Ownership snapshot

Top reported holders of PHIO - PHIO PHARMACEUTICALS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gerrit Dispersyn
Disclosed value leader
Gerrit Dispersyn
Comparable rows
0/15
Latest evidence
31 Mar 2022
3/4/5 13F Highest disclosed value: $320,614 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Gerrit Dispersyn has the largest disclosed position value at $320.6K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gerrit Dispersyn's linked filing trail.
Disclosed position value Top 5
Gerrit Dispersyn $320.6K
VANGUARD GROUP INC $269K
GEODE CAPITAL MANAGEMENT, LLC $95K
Cetera Investment Advisers $80K
TWO SIGMA ADVISERS, LP $41K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gerrit Dispersyn
3/4/5
President & CEO, Director
—
denominator unverified
$320,614
212,327 shares
— 01 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$269,000
304,119 shares
— 31 Mar 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$95,000
107,192 shares
— 31 Mar 2022
Cetera Investment Advisers
13F
Company
13F
—
denominator unverified
$80,000
90,000 shares
— 31 Mar 2022
TWO SIGMA ADVISERS, LP
13F
Company
13F
—
denominator unverified
$41,000
46,700 shares
— 31 Mar 2022
Virtu Financial LLC
13F
Company
13F
—
denominator unverified
$38,000
42,687 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
10
Shares
779,036
Rows available
10
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
12
Q2 2022 holders
10
Holder diff
-2
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .